Mystery of MAHA: Hypertension’s Twist over Cancer’s Shadow
Microangiopathic hemolytic anemia (MAHA) refers to nonimmune hemolysis resulting from the intravascular fragmentation of red blood cells. The etiology of such disorders can range from primary thrombotic microangiopathic syndromes (TMA) to various systemic conditions, posing a diagnostic challenge. Prompt identification requires a sharp clinical assessment to improve outcomes.
Authors
- Nagesh Jadhav (ORCID: https://orcid.org/0000-0001-8993-3947)
- Gregory C Vachon
- Andrew Takla (ORCID: https://orcid.org/0009-0002-2375-7957)
- Jeremy M.L. Hix (ORCID: https://orcid.org/0000-0002-9593-787X)
Institutions
- Rochester General Hospital (US)
Publication Details
- Journal
- Advances in Clinical Medical Research and Healthcare Delivery
- Published
- 2025-05-05
- DOI
- https://doi.org/10.53785/2769-2779.1272
- Primary Topic
- Nutrition, Genetics, and Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00